Importer of Controlled Substances Registration

Download PDF
Federal RegisterAug 10, 2016
81 Fed. Reg. 52908 (Aug. 10, 2016)

ACTION:

Notice of registration.

SUMMARY:

Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION:

The companies listed below applied to be registered as an importer of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

81 FR 120881 FR 1556081 FR 20417
Company FR Docket Published
Mylan Pharmaceuticals, Inc. 80 FR 75691 December 3, 2015.
Hospira January 11, 2016.
Cambrex Charles City 81 FR 14892 March 18, 2016.
Pharmacore 81 FR 15565 March 23, 2016.
Mallinckrodt LLC 81 FR 15566 March 23, 2016.
Meda Pharmaceuticals, Inc. March 23, 2016.
Stepan Company April 7, 2016

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.

Dated: August 2, 2016.

Louis J. Milione,

Deputy Assistant Administrator.

[FR Doc. 2016-18922 Filed 8-9-16; 8:45 am]

BILLING CODE 4410-09-P